Dublin, Ireland, 08 September 2022 – Orphan Drug Consulting is delighted to announce the appointment of Mike Gannon as Chief Financial Officer of Orphan Drug Consulting.

Mike joined Orphan Drug Consulting in June 2020 as a Consultant specializing in helping client organizations grow and develop internationally, as well as advising on appropriate structures for finance, tax, treasury, and business administration and support functions. Over the past two years, Mike has supported many clients in entity structuring, tax compliance, and financial and strategic management for country-specific product launches and routes to market for clients in multiple regions. Mike has contributed directly to the success of Orphan Drug Consulting through his continuous delivery of clients’ needs. Mike has over 25 years of financial leadership experience within pharmaceutical services and wider healthcare and technology sectors including 9 years with UDG Healthcare plc where, as a member of the senior leadership team, Mike played a key role in developing and implementing its international growth strategy and had responsibility for putting in place appropriate business structures to support this expansion.

While working with Coopers & Lybrand (now PricewaterhouseCoopers), Mike qualified as a Chartered Accountant (FCA) and holds a Bachelor of Commerce degree from the National University of Ireland in Galway. Mike also has a Diploma in Professional Accounting (DPA) from University College Dublin (UCD) and has completed the Stanford Executive Program at Stanford Graduate School of Business.

Evelyn Kelly, Founder and Chief Executive Officer of Orphan Drug Consulting commented on Mike’s appointment: “I am delighted to welcome Mike to the executive management team. After working alongside Mike for the past two years, it’s evident he has played a key role in the ongoing success of Orphan Drug Consulting. His executive leadership background makes a great addition to the team as he continues to support our existing and new clients.”

Mike adds: “I am delighted to take on the position of Chief Financial Officer for Orphan Drug Consulting at this exciting time of expansion. I look forward to continuing to work alongside the Orphan Drug Consulting team and leverage my experience for our current and future clients.”

About Orphan Drug Consulting Ltd
Orphan Drug Consulting coordinates product launches into the US, EU, and other international markets providing strategic support in the areas of supply chain, quality assurance, vendor management, and entity management with its team of experienced industry professionals. From full-service solutions to solving specific immediate requirements, Orphan Drug Consulting is your partner of choice to manage market complexities ensuring your successful product launch to meet your patient’s needs.

For more information contact Info@orphandrugconsulting.com

Leave a reply